Form 8.3 - Willis Towers Watson plc - Amendment

LONDON--()-- 

Ap19

FORM 8.3 - Amendment to Sales

IRISH TAKEOVER PANEL

DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013

DEALINGS BY PERSONS WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE

1. KEY INFORMATION

Name of person dealing (Note 1) Barclays PLC.
Company dealt in WILLIS TOWERS WATSON PLC
Class of relevant security to which the ORD
dealings being disclosed relate (Note 2)
Date of dealing 09 June 2020

2. INTERESTS AND SHORT POSITIONS

(a) Interests and short positions (following dealing) in the class of relevant security dealt in (Note 3)

Class of relevant security:

ORD

 

 

Long

Short

Number

(%)

Number

(%)

(1)

Relevant securities

 

 

 

 

950,711

0.74%

625,677

0.49%

 

 

 

 

(2)

Derivatives (other than options):

 

 

 

 

601,000

0.47%

395,159

0.31%

 

 

 

 

(3)

Options and agreements to

 

 

 

 

purchase/sell:

0

0.00%

0

0.00%

 

 

 

 

TOTAL:

 

 

 

 

1,551,711

1.21%

1,020,836

0.79%

 

 

 

 

(b) Interests and short positions in relevant securities of the company, other than the class dealt in (Note 3)

Class of relevant security:

Long

Short

 

Number

 

(%)

Number

 

(%)

(1) Relevant securities

 

 

 

(2) Derivatives (other than options)

 

 

 

(3) Options and agreements to purchase/sell

 

 

Total

 

 

 

Ap20

1. DEALINGS (Note 4)

(a) Purchases and sales

Purchase/sale

Number of relevant securities

Price per unit
Purchase

2

202.3700 USD
Purchase

3

201.5300 USD
Purchase

3

201.2400 USD
Purchase

30

202.8000 USD
Purchase

53

201.1800 USD
Purchase

60

200.9200 USD
Purchase

73

201.9300 USD
Purchase

100

203.5200 USD
Purchase

101

201.9800 USD
Purchase

200

201.1500 USD
Purchase

213

201.7868 USD
Purchase

213

202.9470 USD
Purchase

226

203.1923 USD
Purchase

230

201.1311 USD
Purchase

232

201.0000 USD
Purchase

320

201.6346 USD
Purchase

320

201.3693 USD
Purchase

354

203.3395 USD
Purchase

370

201.9154 USD
Purchase

399

203.0467 USD
Purchase

481

202.5304 USD
Purchase

514

202.2773 USD
Purchase

672

203.0112 USD
Purchase

744

201.9427 USD
Purchase

844

202.1930 USD
Purchase

892

202.2436 USD
Purchase

934

202.1297 USD
Purchase

1,368

202.0251 USD
Purchase

1,382

201.4152 USD
Purchase

1,443

201.7813 USD
Purchase

1,645

201.0261 USD
Purchase

2,103

201.3733 USD
Purchase

2,224

202.1084 USD
Purchase

2,540

202.0164 USD
Purchase

2,576

202.0123 USD
Purchase

3,100

202.6785 USD
Purchase

3,101

202.4345 USD
Purchase

3,104

200.9632 USD
Purchase

3,638

201.5466 USD
Purchase

4,051

201.0100 USD
Purchase

4,758

202.4909 USD
Purchase

4,948

201.7966 USD
Purchase

5,963

201.7791 USD
Purchase

10,057

201.5338 USD
Purchase

11,523

202.0162 USD
Purchase

11,586

201.3868 USD
Purchase

17,083

201.7442 USD
Purchase

64,237

201.2813 USD
Sale

2

202.3700 USD
Sale

6

201.2400 USD
Sale

10

203.7000 USD
Sale

53

203.0700 USD
Sale

100

200.2700 USD
Sale

100

202.3550 USD
Sale

100

202.0000 USD
Sale

149

200.7971 USD
Sale

200

203.1700 USD
Sale

232

201.0000 USD
Sale

400

202.4500 USD
Sale

444

201.7667 USD
Sale

600

202.5475 USD
Sale

600

201.9883 USD
Sale

731

200.9697 USD
Sale

900

201.8238 USD
Sale

1,150

200.9910 USD
Sale

1,293

201.3010 USD
Sale

1,300

202.9681 USD
Sale

2,318

201.2900 USD
Sale

2,600

201.2571 USD
Sale

3,151

201.5638 USD
Sale

3,548

201.5132 USD
Sale

3,550

201.7147 USD
Sale

3,936

201.2827 USD
Sale

4,149

201.4311 USD
Sale

4,363

202.6783 USD
Sale

4,126

201.0100 USD
Sale

5,187

202.4432 USD
Sale

6,050

201.2178 USD
Sale

6,547

201.4953 USD
Sale

10,251

201.4556 USD
Sale

14,787

201.3553 USD
Sale

27,563

201.7789 USD
Sale

29,759

201.1418 USD
Sale

30,707

201.9585 USD

(b) Derivatives transactions (other than options transactions)

Product name,

e.g. CFD

Nature of transaction

(Note 6)

Number of relevant securities

(Note 7)

Price per unit

(Note 5)

 

 

 

 

(c) Options transactions in respect of existing relevant securities

(i) Writing, selling, purchasing or varying

Product name,

e.g. call option

Writing, selling, purchasing, varying etc.

Number of securities to which the option relates (Note 7)

Exercise price

Type, e.g. American, European etc.

Expiry date

Option money paid/received per unit (Note 5)

 

 

 

 

 

 

 

(ii) Exercising

Product name,

e.g. call option

Number of securities

Exercise price per unit (Note 5)

 

 

 

(d) Other dealings (including transactions in respect of new securities) (Note 4)

Nature of transaction

(Note 8)

Details

Price per unit

(if applicable) (Note 5)

 

 

 

 

Ap21

2. OTHER INFORMATION

Agreements, arrangements or understandings relating to options or derivatives

Full details of any agreement, arrangement or understanding between the person disclosing and any other person relating to the voting rights of any relevant securities under any option referred to on this form or relating to the voting rights or future acquisition or disposal of any relevant securities to which any derivative referred to on this form is referenced. If none, this should be stated.

None

Is a Supplemental Form 8 (Open Positions) attached? NO
Date of disclosure:

12 Jun 2020

Contact name:

Large Holdings Regulatory Operations

Telephone number:

020 3134 7213

If a connected EFM, name of offeree/offeror with which connected
If a connected EFM, state nature of connection

 

Short Name: BARCLAYS PLC
Category Code: RET
Sequence Number: 701719
Time of Receipt (offset from UTC): 20200612T131818+0100

Contacts

BARCLAYS PLC

Contacts

BARCLAYS PLC